| 000 | 01885 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250515210314.0 | ||
| 264 | 0 | _c20100429 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1476-4687 | ||
| 024 | 7 |
_a10.1038/nature08825 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFellay, Jacques | |
| 245 | 0 | 0 |
_aITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. _h[electronic resource] |
| 260 |
_bNature _cMar 2010 |
||
| 300 |
_a405-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAnemia, Hemolytic _xchemically induced |
| 650 | 0 | 4 | _aAntiviral Agents |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 20 |
| 650 | 0 | 4 |
_aEurope _xethnology |
| 650 | 0 | 4 |
_aGenetic Variation _xgenetics |
| 650 | 0 | 4 | _aGenome-Wide Association Study |
| 650 | 0 | 4 |
_aHemoglobins _xdeficiency |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aPyrophosphatases _xdeficiency |
| 650 | 0 | 4 |
_aRacial Groups _xgenetics |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aInosine Triphosphatase |
| 700 | 1 | _aThompson, Alexander J | |
| 700 | 1 | _aGe, Dongliang | |
| 700 | 1 | _aGumbs, Curtis E | |
| 700 | 1 | _aUrban, Thomas J | |
| 700 | 1 | _aShianna, Kevin V | |
| 700 | 1 | _aLittle, Latasha D | |
| 700 | 1 | _aQiu, Ping | |
| 700 | 1 | _aBertelsen, Arthur H | |
| 700 | 1 | _aWatson, Mark | |
| 700 | 1 | _aWarner, Amelia | |
| 700 | 1 | _aMuir, Andrew J | |
| 700 | 1 | _aBrass, Clifford | |
| 700 | 1 | _aAlbrecht, Janice | |
| 700 | 1 | _aSulkowski, Mark | |
| 700 | 1 | _aMcHutchison, John G | |
| 700 | 1 | _aGoldstein, David B | |
| 773 | 0 |
_tNature _gvol. 464 _gno. 7287 _gp. 405-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nature08825 _zAvailable from publisher's website |
| 999 |
_c19542981 _d19542981 |
||